This opportunity represents the acquisition of a distinguished aesthetics and wellness enterprise based in Marylebone, London. As a private limited company wholly owned by the founder, the business has positioned itself as a leader in the UK’s burgeoning health and beauty sector. Specialising in intravenous (IV) and intramuscular (IM) vitamin therapies, transdermal wellness innovations, and premium skincare solutions, the Company combines clinical expertise with consumer-centric product development. Its strategic central London location, coupled with a reputation for award-winning formulations and sustainable practices, makes it an attractive proposition for investors seeking entry into the £1.7 billion UK vitamin and supplement market. The current shareholder is pursuing a strategic partnership or acquisition to accelerate growth through enhanced digital marketing, geographic expansion, and e-commerce optimisation.
For investors seeking entry into a premium, sustainability-focused brand with proven traction and room for innovation, this opportunity offers both immediate revenue potential and long-term strategic advantages. In a market increasingly defined by health-conscious consumption and aesthetic innovation, this business stands as a beacon of quality and growth. Interested parties are encouraged to act swiftly to secure a stake in this forward-thinking enterprise.
Offers are invited and Enquiries are encouraged.
